Medical Oncology Hematology Consultants - Newark

Newark, Delaware 19713-2055

0 studies enrolling now · 1 studies all time

What they study most

Prostatic Neoplasms, Castration-Resistant

Studies at this site

• A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer — Stopped early